Literature DB >> 4555145

Drug therapy of parkinsonism.

M D Yahr, R C Duvoisin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4555145     DOI: 10.1056/NEJM197207062870105

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Effects of desipramine on neuronal responses to dopamine, noradrenaline, 5-hydroxytryptamine and acetylcholine in the caudate nucleus of the rat.

Authors:  P Bevan; C M Bradshaw; E Szabadi
Journal:  Br J Pharmacol       Date:  1975-07       Impact factor: 8.739

Review 2.  Milestones in research on the pathophysiology of Parkinson's disease.

Authors:  Thomas Wichmann; Mahlon R DeLong; Jorge Guridi; Jose A Obeso
Journal:  Mov Disord       Date:  2011-05       Impact factor: 10.338

3.  Treatment of Parkinson's Disease with levodopa and amantadine used as single drugs and in combined therapy.

Authors:  N Callagham; M Mcllroy; M O'Connor
Journal:  Ir J Med Sci       Date:  1974-03       Impact factor: 1.568

4.  Interactions between levodopa and other drugs: significance in the treatment of Parkinson's disease.

Authors:  J R Bianchine; L Sunyapridakul
Journal:  Drugs       Date:  1973       Impact factor: 9.546

Review 5.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

6.  Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease.

Authors:  J D Parkes; R C Baxter; C D Marsden; J E Rees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154

7.  A pharmacological study of the adrenergic mechanisms involved in the stretch reflex of the decerebrate rat.

Authors:  J W Commissiong; E M Sedgwick
Journal:  Br J Pharmacol       Date:  1974-03       Impact factor: 8.739

Review 8.  Impact of Tremor on Patients With Early Stage Parkinson's Disease.

Authors:  Lauren E Heusinkveld; Mallory L Hacker; Maxim Turchan; Thomas L Davis; David Charles
Journal:  Front Neurol       Date:  2018-08-03       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.